Come up with a name for your new list and we'll add to it:
PathoVax raised a round of funding on July 12, 2017. Investors include
Harvard Venture Incubation Program.
PathoVax is a biotech company developing a cost-effective human papillomavirus (HPV) vaccine machine with universal protection. PathoVax's pilot vaccine RGVax promises to provide protection against al…